Drug combinations sold in India lack regulatory nod

Mumbai: Almost two-thirds of the drug combinations widely sold in India to fight pain, depression, and psychotic conditions lack the necessary regulatory approvals, despite some of the pills being banned internationally, a study published on Tuesday shows.

India’s reputation as a reliable supplier of cheap generic medicines has taken a hit after sanctions by the United States and Britain faced by some of its largest drugmakers over violations of standard drug-making practices.
Thousands of fixed-dose combination drugs (FDCs), or cocktails of two or more medicines, are sold in India. While many are safe and effective, including those used to treat HIV and tuberculosis, others have been found unsafe and even dangerous, said the researchers who ran the study

Kindly send reply or comments on this topic to reporter@newsforyou.in
Source:Ibnlive

Popular Diabetics Medicines